Ivana Maida
Ivana Maida
Unknown affiliation
Verified email at
Cited by
Cited by
Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients
P Labarga, V Soriano, ME Vispo, J Pinilla, L Martín-Carbonero, ...
The Journal of infectious diseases 196 (5), 670-676, 2007
Severe liver disease associated with prolonged exposure to antiretroviral drugs
I Maida, M Núñez, MJ Ríos, L Martín-Carbonero, G Sotgiu, C Toro, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 42 (2), 177-182, 2006
Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy
S Babudieri, B Longo, L Sarmati, G Starnini, L Dori, B Suligoi, ...
Journal of medical virology 76 (3), 311-317, 2005
Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir
E Vispo, P Barreiro, JA Pineda, JA Mira, I Maida, L Martín-Carbonero, ...
Antiviral therapy 13 (3), 429-438, 2008
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine
A Barrios, A Rendón, E Negredo, P Barreiro, T Garcia-Benayas, ...
Aids 19 (6), 569-575, 2005
Rickettsia monacensis as cause of Mediterranean spotted fever–like illness, Italy
G Madeddu, F Mancini, A Caddeo, A Ciervo, S Babudieri, I Maida, ...
Emerging infectious diseases 18 (4), 702, 2012
Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings
E Vispo, A Moreno, I Maida, P Barreiro, A Cuevas, S Albertos, V Soriano
Aids 24 (8), 1171-1176, 2010
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome
I Maida, P Garcia-Gasco, G Sotgiu, MJ Rios, ME Vispo, ...
Antiviral Therapy 13 (1), 103-108, 2008
Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies
VC Di Maio, V Cento, I Lenci, M Aragri, P Rossi, S Barbaliscia, M Melis, ...
Liver international 37 (4), 514-528, 2017
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies
V Soriano, I Maida, M Núñez, J García-Samaniego, P Barreiro, ...
Antiviral therapy 9 (6), 987-992, 2004
HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications
M Andreoni, A Giacometti, I Maida, P Meraviglia, D Ripamonti, L Sarmati
Eur Rev Med Pharmacol Sci 16 (11), 1473-1483, 2012
Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome
P Garcia-Gasco, I Maida, F Blanco, P Barreiro, L Martín-Carbonero, ...
Journal of antimicrobial chemotherapy 61 (3), 699-704, 2008
Serum homocysteine levels are increased in women with gestational diabetes mellitus
G Seghieri, MC Breschi, R Anichini, A De Bellis, L Alviggi, I Maida, ...
Metabolism 52 (6), 720-723, 2003
Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands.
F Vitale, DV Briffa, D Whitby, I Maida, A Grochowska, A Levin, N Romano, ...
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?
G Mameli, G Madeddu, A Mei, E Uleri, L Poddighe, LG Delogu, I Maida, ...
PLoS One 8 (11), e78474, 2013
Comorbidities, cardiovascular therapies, and COVID-19 mortality: a nationwide, Italian observational study (ItaliCO)
F Polverino, DA Stern, G Ruocco, E Balestro, M Bassetti, M Candelli, ...
Frontiers in cardiovascular medicine 7, 585866, 2020
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin
MG Antonini, S Babudieri, I Maida, C Baiguera, B Zanini, L Fenu, G Dettori, ...
Infection 36, 250-255, 2008
Modulation by α-and γ-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human coronary smooth muscle cells∗
F de Nigris, F Franconi, I Maida, G Palumbo, V Anania, C Napoli
Biochemical pharmacology 59 (11), 1477-1487, 2000
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes
A De Vito, V Fiore, E Princic, N Geremia, CM Panu Napodano, ...
PLoS One 16 (3), e0248009, 2021
Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C
E Vispo, A Mena, I Maida, F Blanco, M Cordoba, P Labarga, ...
Journal of antimicrobial chemotherapy 65 (3), 543-547, 2010
The system can't perform the operation now. Try again later.
Articles 1–20